Ovid Therapeutics (OVID) traded down -8.86 % during a 24 hours period ending at 10:48 PM Central Europe on Monday 26th. One Ovid Therapeutics stock can currently be bought for about USD 2.15 on popular exchanges. Current supply of Ovid Therapeutics stocks is 195.3 mn. Ovid Therapeutics has a current market capitalization of USD 421.8 mn and approximately USD 4.4 mn worth of Ovid Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Ovid Therapeutics has traded -13.43 % down. Simple moving average of last 200 days is at USD 2.34. The highest price of past 52 weeks was recorded at USD 3.1 on 04/09/2026. 52 weeks low was at USD 1.18 on 11/14/2025.
Here is how related stocks have performed in the past 24 hours:
Ponce (PDLB) traded up 0.73 % and now trades at USD 21.26. Current market capitalisation for Ponce is USD 498.8 mn. Current price/earnings ratio for Ponce is 14.54.
Cytomx Therapeutics (CTMX) traded down -4.92 % and now trades at USD 2.22. Cytomx Therapeutics has a market capitalisation of USD 505.5 mn.
Sight Sciences (SGHT) traded down -1.1 % and now trades at USD 9.02. Current market capitalisation for Sight Sciences is USD 495.2 mn.
Delcath (DCTH) traded down -2.24 % and now trades at USD 14.51. Delcath has a market capitalisation of USD 500.4 mn. Delcath has a current price to earnings ratio of 976.87.
Aquestive Therapeutics (AQST) traded down -3.15 % and now trades at USD 3.97. Aquestive Therapeutics has a market capitalisation of USD 502.1 mn.
About Ovid Therapeutics
Ovid Therapeutics Inc. is a biopharmaceutical company that specializes in developing medications for patients and families living with rare neurological disorders. The company operates in the Health Care sector and is listed on the Nasdaq stock exchange. Their website is www.ovidrx.com , and they held their Initial Public Offering (IPO) on May 5, 2017.
